Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 1;93(2):242-51.
doi: 10.1093/cvr/cvr292. Epub 2011 Nov 2.

Arrhythmogenic consequences of myofibroblast-myocyte coupling

Affiliations

Arrhythmogenic consequences of myofibroblast-myocyte coupling

Thao P Nguyen et al. Cardiovasc Res. .

Abstract

Aims: Fibrosis is known to promote cardiac arrhythmias by disrupting myocardial structure. Given recent evidence that myofibroblasts form gap junctions with myocytes at least in co-cultures, we investigated whether myofibroblast-myocyte coupling can promote arrhythmia triggers, such as early afterdepolarizations (EADs), by directly influencing myocyte electrophysiology.

Methods and results: Using the dynamic voltage clamp technique, patch-clamped adult rabbit ventricular myocytes were electrotonically coupled to one or multiple virtual fibroblasts or myofibroblasts programmed with eight combinations of capacitance, membrane resistance, resting membrane potential, and gap junction coupling resistance, spanning physiologically realistic ranges. Myocytes were exposed to oxidative (1 mmol/L H(2)O(2)) or ionic (2.7 mmol/L hypokalaemia) stress to induce bradycardia-dependent EADs. In the absence of myofibroblast-myocyte coupling, EADs developed during slow pacing (6 s), but were completely suppressed by faster pacing (1 s). However, in the presence of myofibroblast-myocyte coupling, EADs could no longer be suppressed by rapid pacing, especially when myofibroblast resting membrane potential was depolarized (-25 mV). Analysis of the myofibroblast-myocyte virtual gap junction currents revealed two components: an early transient-outward I(to)-like current and a late sustained current. Selective elimination of the I(to)-like component prevented EADs, whereas selective elimination of the late component did not.

Conclusion: Coupling of myocytes to myofibroblasts promotes EAD formation as a result of a mismatch in early vs. late repolarization reserve caused by the I(to)-like component of the gap junction current. These cellular and ionic mechanisms may contribute to the pro-arrhythmic risk in fibrotic hearts.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Induction of bradycardia-dependence of EAD by hypokalaemia or H2O2. A patch-clamped rabbit myocyte was superfused with Tyrode's solution containing normal 5.4 mmol/L K+ (A), reduced 2.7 mmol/L K+ (B), or 1.0 mmol/L H2O2 (in normal 5.4 mmol/L K+) (C). Both hypokalaemia and oxidative stress with H2O2 caused EADs (*) at long pacing cycle lengths (PCL) but not at PCL 1 s.
Figure 2
Figure 2
Promotion of EADs by myofibroblast–myocyte coupling. (A) Coupling a patch-clamped myocyte superfused with normal Tyrode's solution to a virtual fibroblast did not induce EADs at PCL 1 s. Superimposed traces at a faster time scale to the right illustrate that coupling lowers the AP plateau and shortens ADP. (B and C) In myocytes exposed to hypokalaemia or H2O2 to induce bradycardia-dependent EADs at PCL 6 s (not shown), pacing at PCL 1 s suppressed EADs completely (top traces). However, coupling the myocyte to a virtual fibroblast (Cf 6.3 pF, Gj 3.0 nS) caused EADs to reappear, which were more prominent when Ef was −25 mV (bottom traces) than −50 mV (middle traces). In addition to EADs, DADs (some triggering APs) were also frequently observed (arrows). Lower panels show superimposed traces of control vs. coupled for the Ef −50 and −25 mV cases, respectively, at a faster time scale. Note that coupling lowers the early AP plateau voltage before EAD onset.
Figure 3
Figure 3
Data summary of EAD reappearance at PCL 1 s induced by myocyte–myofibroblast 1:1 coupling. Patch-clamped myocytes were exposed to H2O2 to induce bradycardia-dependent EADs at PCL 6 s, which were then suppressed at PCL 1 s. Bars indicate the fraction of myocytes in which EADs reappeared when the myocyte was coupled to a virtual myofibroblast, for each of the eight different coupling parameter sets listed in Table 1. The total number of ventricular myocytes tested for each coupling parameter set is indicated inside each bar, with the corresponding probability of EAD reappearance shown above.
Figure 4
Figure 4
Higher probability of EAD induction by coupling multiple myofibroblasts to a single myocyte. A patch-clamped myocyte was exposed to H2O2 to induce bradycardia-dependent EADs at PCL 6 s, which were then suppressed at PCL 1 s. Coupling the myocyte (MC) to one myofibroblast (MF, with Cf 50.0 pF, Gj 3.0 nS, Ef −25 mV) depolarized the myocyte and shortened APD (middle trace), but did not cause EADs to reappear. However, when the myocyte was coupled to two myofibroblasts in parallel (effectively increasing Cf to 100 pF and Gj to 6 nS), EADs and repolarization failure ensued (lower trace).
Figure 5
Figure 5
Effects of Ef vs. Gf on EAD threshold. Threshold for EAD formation (see text) of the myofibroblast-coupled state was compared with that of the control myofibroblast-uncoupled state. (A) Coupling a passive myofibroblast model to a Luo-Rudy 1 myocyte AP model to simulate the same eight coupling combinations tested experimentally in Table 1 lowered EAD threshold much more prominently for high Ef–high Gf (Ef −25 mV/Gf 123 pS) cases than for low Ef–low Gf (Ef −50 mV/Gf 26 pS) cases. (B) When Ef was kept low at −50 mV for all eight parameter combinations, Gf had little effect or increased EAD threshold. (C) When Ef was held high at −25 mV for all eight parameter combinations, Gf decreased EAD threshold in all cases, indicating that high Ef is more important than high Gf at lowering EAD threshold. Numbers indicate the per cent change in EAD threshold.
Figure 6
Figure 6
The early Ito-like component of Ij promotes EADs. (A) A patch-clamped myocyte was exposed to 1.0 mmol/L H2O2 to induce bradycardia-dependent EADs at PCL 6 s, which were then suppressed at PCL 1 s (not shown). Coupling the myocyte to a virtual fibroblast (Cf6.3pF, Ef −25 mV, Gj 0.3 nS) (left upper trace) caused EADs to reappear. The virtual gap junction current Ij (left lower trace) consisted of an early transient outward Ito-like component followed by a sustained component. When coupling was allowed only during the first 100 ms of the AP, the EAD persisted (middle upper trace). However, when coupling was allowed only during the last 900 ms, the EAD disappeared (right upper trace). (B) Corresponding simulation: same protocol as in (A), but with the real myocyte replaced by the Luo-Rudy 1 ventricular AP model modified to produce bradycardia-induced EADs. EADs reappear at PCL 1 s when coupling to the fibroblast is present throughout the cardiac cycle (left) or only the first 100 ms of the AP (middle), but not when uncoupled during the first 100 ms of the AP (right). Bottom row shows expanded traces of the corresponding gap junction currents Ij.

Comment in

References

    1. Camelliti P, Devlin GP, Matthews KG, Kohl P, Green CR. Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovasc Res. 2004;62:415–425. - PubMed
    1. Chilton L, Giles WR, Smith GL. Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol. 2007;583:225–236. - PMC - PubMed
    1. Rook MB, van Ginneken AC, de Jonge B, el Aoumari A, Gros D, Jongsma HJ. Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs. Am J Physiol. 1992;263:C959–C977. - PubMed
    1. Jacquemet V. Pacemaker activity resulting from the coupling with nonexcitable cells. Phys Rev E Stat Nonlin Soft Matter Phys. 2006;74:011908. - PubMed
    1. Miragoli M, Salvarani N, Rohr S. Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res. 2007;101:755–758. - PubMed

Publication types